Mayo Clinic News Network

News Resources

Items tagged as "liver disease"

Combination Therapy Offers Quicker, Less Toxic Eradication of Hepatitis C in Patients with Transplanted Livers

Combination Therapy Offers Quicker, Less Toxic Eradication of Hepatitis C in Patients with Transplanted Livers

http://youtu.be/cTjpk2XwSNc JACKSONVILLE, Fla., Nov. 9, 2014 — All patients with hepatitis C who receive a liver transplant will eventually infect their new livers. These transplanted organs then require anti-viral treatment before they become severely damaged. But traditional post-transplant hepatitis C therapy can take up to a year, is potentially toxic [...]

Created by Paul Scotti

Pungpapong: HepC Study – Edited PKG (2:53)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – Next Few Years (:22)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – Background of Study (:29)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – Study Findings (:26)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – Objective of Study (:17)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – Hep C recurrence (:29)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Pungpapong: HepC Study – FDA Approval (:15)

Surakit Pungpapong, M.D., transplant hepatologist and associate professor of medicine at Mayo Clinic in Florida, talks about his latest study, how two new oral medications, used post –liver transplant – are safe and beneficial in the treatment of Hepatitis C and require only 12 weeks of treatment instead of up [...]

Created by Jason Pratt

Load More